<DOC>
	<DOCNO>NCT00412100</DOCNO>
	<brief_summary>The primary objective demonstrate patient take oxycodone/naloxone prolong release tablet improvement symptom constipation compare subject take oxycodone prolong release tablet alone .</brief_summary>
	<brief_title>Oxycodone-naloxone Prolonged Release Tablets Relieving Opioid-related Constipation</brief_title>
	<detailed_description>Patients document history moderate severe non-malignant pain require around-the-clock opioid therapy randomise oxycodone oxycodone-naloxone treatment arm . The primary objective demonstrate patient take oxycodone/naloxone prolong release tablet improvement symptom constipation compare subject take oxycodone prolong release tablet alone .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Male female subject least 18 year old moderate severe pain require around clock opioid therapy . Subjects must report constipation cause aggravated opioids . Females pregnant lactating . Subjects evidence clinically unstable disease subject evidence impair liver/kidney function upon entry study . Subjects evidence significant structural abnormality gastrointestinal tract .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>A randomised</keyword>
	<keyword>double-blind</keyword>
	<keyword>double-dummy</keyword>
	<keyword>parallel-group multicentre study demonstrate improvement symptom constipation</keyword>
	<keyword>Moderate severe , chronic non-malignant pain</keyword>
</DOC>